Cannabidiol

The Mental Health America organization has designated each May as Mental Health Awareness Month.

The FDA’s Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee denied Pfizer’s risk mitigation proposal for its osteoarthritis drug tanezumab. A recap of the hearing was the top story in rheumatology last week.

The FDA has issued warning letters to Honest Globe Inc. and Biolyte Laboratories LLC for allegedly illegally marketing unapproved, over-the-counter drugs labeled as containing cannabidiol, or CBD, for arthritis and other pain indications.

Use of a cannabidiol sublingual product may reduce severe anxiety and anxiety-related symptoms, according to a presentation at the Anxiety and Depression Association of America annual conference.

In a recent social media survey, 90% of patients with migraine said they use complementary and integrative medicines like meditation, yoga and vitamins, but only about 20% discuss these treatment strategies with a health care provider.

Cannabis strains that contain mostly cannabidiol and almost no tetrahydrocannabinol were not significantly associated with impaired driving, according to research published in JAMA.

Some patients with cancer use cannabidiol products to manage pain and other adverse effects of treatment, but what are the risks associated with these products? A recent review of this was the top story in hematology/oncology last week.

Pain and other common adverse effects of cancer treatment — such as nausea and vomiting, mucositis, depression or anxiety — can dramatically decrease quality of life.

Healio Psychiatry has compiled a list of its five most-viewed stories in August.

Cannabidiol appeared to increase cerebral blood flow to brain regions involved in memory processing, according to results of an MRI study published in Journal of Psychopharmacology.